NEW YORK--(BUSINESS WIRE)--Neurogene Inc., a company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced results of a well ...
- Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track designation - CHARLESTOWN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Solid ...
DUBLIN--(BUSINESS WIRE)--The "Anticoagulants Market Global Forecast Report by Drug Class, Route of Administration, Distribution Channel, Application, Countries and Company Analysis 2025-2033" report ...
Hosted on MSN
Merck Says EMA Committee Adopted Two Positive Opinions For Expanding Use Of Cancer Drug Keytruda
European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted two positive opinions for Merck’s (MRK) blockbuster cancer drug Keytruda, the company said on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results